Jiangsu Bioperfectus Technologies Co Ltd (688399) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.007x

Based on the latest financial reports, Jiangsu Bioperfectus Technologies Co Ltd (688399) has a cash flow conversion efficiency ratio of 0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥20.00 Million ≈ $2.93 Million USD) by net assets (CN¥2.97 Billion ≈ $434.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jiangsu Bioperfectus Technologies Co Ltd (688399) liquidity interval to measure how many days the company can operate on defensive assets alone.

Jiangsu Bioperfectus Technologies Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Jiangsu Bioperfectus Technologies Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jiangsu Bioperfectus Technologies Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Bioperfectus Technologies Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sturm Ruger & Company Inc NYSE:RGR	0.046x
Shanghai Rongtai Health Tech SHG:603579	-0.006x
Amata Corporation Public Company Limited BK:AMATA-R	0.062x
AB Siauliu Bankas F:ZH5	-0.078x
Yabao Pharmaceutical Group Co Ltd SHG:600351	0.047x
IFE Elevators Co Ltd SHE:002774	0.051x
Grupo KUO S.A.B. de C.V MX:KUOB	0.005x
Farglory FTZ Investment Holding Co Ltd TW:5607	0.041x

Annual Cash Flow Conversion Efficiency for Jiangsu Bioperfectus Technologies Co Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Jiangsu Bioperfectus Technologies Co Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Jiangsu Bioperfectus Technologies Co Ltd (688399) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.25 Billion ≈ $475.67 Million	CN¥145.93 Million ≈ $21.35 Million	0.045x	+235.10%
2023-12-31	CN¥3.41 Billion ≈ $498.27 Million	CN¥-113.14 Million ≈ $-16.56 Million	-0.033x	-106.39%
2022-12-31	CN¥3.78 Billion ≈ $552.86 Million	CN¥1.96 Billion ≈ $287.52 Million	0.520x	+33.85%
2021-12-31	CN¥2.54 Billion ≈ $371.16 Million	CN¥985.52 Million ≈ $144.21 Million	0.389x	-30.90%
2020-12-31	CN¥1.66 Billion ≈ $243.57 Million	CN¥935.88 Million ≈ $136.95 Million	0.562x	+437.82%
2019-12-31	CN¥1.02 Billion ≈ $149.37 Million	CN¥106.72 Million ≈ $15.62 Million	0.105x	-60.52%
2018-12-31	CN¥324.10 Million ≈ $47.43 Million	CN¥85.82 Million ≈ $12.56 Million	0.265x	+11.90%
2017-12-31	CN¥260.28 Million ≈ $38.09 Million	CN¥61.59 Million ≈ $9.01 Million	0.237x	+169.80%
2016-12-31	CN¥251.90 Million ≈ $36.86 Million	CN¥22.09 Million ≈ $3.23 Million	0.088x	--

About Jiangsu Bioperfectus Technologies Co Ltd

SHG:688399 China Biotechnology

Market Cap

$605.68 Million

CN¥4.14 Billion CNY

Market Cap Rank

#11420 Global

#3266 in China

Share Price

CN¥49.35

Change (1 day)

-2.20%

52-Week Range

CN¥46.53 - CN¥84.90

All Time High

CN¥419.88